Theriva Biologics Statistics
NYSE: TOVXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.2212-0.0059 (-2.60%)
Market open · Delayed 15 min · as of Oct 9, 2:17 PM ET
Theriva Biologics by the numbers
Theriva Biologics has a market capitalization of $10.2 million based on 45.89M shares outstanding. Its trailing P/E ratio is 0.3. The stock trades 5.2% below its 50-day average and 8.1% below its 200-day average.
Average daily trading volume is 525.96K shares, or about $116,343 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TOVX valuation vs. peer median
| Metric | TOVX | Peer median | Difference |
|---|---|---|---|
| Market cap | $10.15M | $10.47M | -3% |
| Avg. volume | 525.96K | 96.01K | +448% |
Peer median across 8 companies: ADIL, GDTC, ENSC, CMMB, VTGN, BLRX, JAGX, KPRX.
Valuation
- Market cap
- $10.15M
- P/E (TTM)
- 0.30
- EPS (TTM)
- $0.73
- Shares outstanding
- 45.89M
Price and trading
- Previous close
- 0.2271
- Open
- 0.2263
- Day range
- 0.22 – 0.2329
- 52-week range
- 0.16 – 0.86
- 52-week change
- -49.53%
- 50-day moving average
- 0.2334
- 200-day moving average
- 0.2406
- Beta
- —
- Volume
- 264.57K
- Average volume
- 525.96K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2025
Additional statistics
- Market Cap
- 10.15M
- Pe
- 0.30
- Forward Pe
- -1.11
- Eps
- 0.73
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 0.86
- Week52 Low
- 0.16
- Avg Volume
- 525.96K
- Shares Outstanding
- 45.89M
- Ma50
- 0.23
- Ma200
- 0.24
- Earnings Date
- Aug 14, 2025
- Pct From52w High
- -74.28%
- Pct From52w Low
- 38.25%